01
Science-first, data-driven
A disciplined investment philosophy focused on longevity and life sciences, grounded in scientific evidence, human data and translational execution.
Anatolia Health Tech
Health today,
Life tomorrow
A gateway to next-generation health technologies.
Anatolia Health Tech is a science-first, data-driven investment platform focused on longevity and life sciences — backing proven assets and building the regional gateway for next-generation health technologies.
Global vision, rooted in Anatolia
Science-first platform
Building a regional health technology powerhouse.
Longevity Life Sciences Health Tech
30MUSD target fund size
10target investments
8 yrsfund life
3anchor portfolio platforms
Core Messages
Science-first capital for longevity and life sciences.
Anatolia Health Tech brings together proven portfolio assets, international investment discipline and world-class scientific guidance to build platforms in the highest-growth areas of health.
Investment Thesis
Türkiye as a cost-effective excellence hub for health innovation.
Anatolia Health Tech is designed around a clear hypothesis: Türkiye's clinical infrastructure, scientific talent and large healthcare market can be transformed into a regional platform for innovative health technology development.
01
Scientific depth
A broad academic and clinical base creates the foundation for translational health technology development.
02
Regional access
Türkiye can serve as a strategic bridge for health technologies across Europe, MENA, CIS and wider emerging markets.
03
Integrated platforms
The fund connects drug discovery, longevity data, cell therapy and clinical implementation into one investment architecture.
Focus Areas
Where health, data and biology converge.
We invest across high-growth health technology fields where scientific evidence, data infrastructure and clinical execution can converge into scalable platforms.
Longevity
Preventive health, biological age, multi-omic data and AI-enabled human insight.
Cell & Gene Therapies
Local production, technology transfer and regional application capability.
AI Drug Discovery
System biology, multi-omic platforms and AI-driven therapeutic development.
Precision Medicine
Genomics, biomarkers, diagnostics and personalized treatment strategies.
Regenerative Medicine
Cell therapies, tissue engineering and next-generation biological interventions.
Digital Health
Remote monitoring, preventive care, clinical decision support and patient interfaces.
Biomanufacturing
GMP-aligned production capabilities and scalable health technology infrastructure.
Regional Platforms
Türkiye-centered expansion models designed for neighboring geographies.
Portfolio Platform
Three anchors for the future of health.
Our platform is anchored by three proven portfolio assets: Trustlife Therapeutics, Phenome Longevity and TCT Health — each addressing a different layer of the future health economy.
Innovative Drug R&D
Trustlife Therapeutics
Integrated drug discovery and development platform using systems biology and multi-omic technologies.
Longevity & Human Data
Phenome Longevity
A preventive health and data platform built on multi-omic human data, AI analysis and personalized health interfaces.
Cell & Gene Therapies
TCT Health
Türkiye-centered cell and gene therapy platform focused on technology transfer, local production and clinical access.
Governance & Exit Logic
International discipline, scientific depth and visible routes to liquidity.
Anatolia Health Tech is structured to combine investment-grade governance with a world-class scientific advisory network and clearly defined exit pathways.
Investment Committee
Internationally validated investment committee experience across McKinsey, Citi, UBS, IQVIA and PwC supports institutional discipline, transaction logic and portfolio governance.
Scientific Advisory Board
World-class scientific perspective connected to King’s College London, KTH and SciLifeLab strengthens scientific validation, translational strategy and global credibility.
- Strategic sale: exit through global pharma, biotech, diagnostics, medtech or digital health players.
- Joint-venture acquisition: structured buyout or consolidation by strategic partners.
- Dual-track IPO: parallel preparation for public markets and strategic M&A.
Health today,
Life tomorrow.
We partner with scientists, founders, strategic investors and institutions building the next era of health technologies.